• About
  • Offices
  • Careers
  • News
  • Students
  • Alumni
  • Payments
  • FR
Bennett Jones Logo Bennett Jones Logo
  • People
  • Expertise
  • Knowledge
  • Search
  • FR Menu
  • Search Mobile
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
View all
Practices
Corporate Litigation Regulatory Tax View all
Industries
Capital Projects Energy Funds & Finance Mining View all
Advisory
Crisis & Risk Management ESG Strategy and Solutions Governmental Affairs & Public Policy
View Client Work
International Experience
Insights News Events
New Energy Economy Series Business Law Talks Podcast Economic Outlook
ESG & the CIO Subscribe
People
Practices
Industries
Advisory Services
Client Work
About
Offices
News
Careers
Insights
Law Students
Events
Search
Alumni
Payments
Subscribe

Stay informed on the latest business and legal insights and events.

LinkedIn LinkedIn Twitter Twitter Vimeo Vimeo
 

Emily P. Kettel

Partner

Partner | Email

T: 416.777.4893

Email

Toronto

Download vCard
Download PDF
LinkedIn
Kettel Emily
 
  • Recent Experience
  • Recent Recognition
  • Insights, News & Events
  • Related Services

T: 416.777.4893


Email

Toronto

Download vCard
Download PDF
LinkedIn
  • Education
  • Bar Admissions
  • Recent Experience
  • Recent Recognition
  • Insights, News & Events
  • Related Services
  • Recent Experience
  • Recent Recognition
  • Insights, News & Events
  • Related Services

Emily Kettel is an intellectual property litigator and registered Canadian trademark agent with more than ten years of experience in patent validity, infringement, trademark litigation, and intellectual property advisory work for clients in the pharmaceutical, biotechnology, and other science-based industries. Emily has extensive knowledge of Canadian drug markets, including generic and biosimilar entry mechanisms and pricing considerations. Emily works with Canadian and international clients to achieve their business objectives in a cost-effective way: she advises on patent and trademark litigation strategy, provides advice regarding the Food and Drugs Act, Medical Devices Regulations and Food and Drugs Regulations, negotiates pre-litigation market entry for pharmaceutical products, drafts and responds to notice letters for biosimilar and generic pharmaceutical entrants, advises on pharmaceutical pricing considerations, and related regulatory matters.

Emily has significant experience in complex, multi-party patent matters involving concurrent litigation in Canada and the U.S. She also has experience in trademark prosecution and advises clients on trademark strategy. Emily was counsel on the first patent validity trial in the amended Patented Medicines (Notice of Compliance) Regulations in 2020 in the Federal Court and its subsequent appeal and is counsel on a related appeal and damages suit, and has advised on strategy and prepared many Notices of Allegation and acted on subsequent litigation, and for both small-molecule generic drugs and biosimilar products.

Emily is a member of the Advocates Society and the Intellectual Property Institute of Canada and is active on the IPIC Patent Committee and Women’s Intellectual Property Networking Group (WING), chairing an annual women’s networking event. Emily has presented to groups on many topics related to intellectual property litigation, including the PM(NOC) Regulations, best practices in discovery and costs awards in the Federal Court. Emily received her Bachelor of Science (Engineering) at the University of Guelph and her Juris Doctor at the University of Toronto Faculty of Law, where she received the Cressy Student Leadership Award and the Judy LaMarsh Prize.

Education

University of Guelph, BSc (Eng), 2005, with distinction  University of Toronto, JD, 2008 

Bar Admissions

Ontario, 2009

Recent Experience

Amgen Inc. and Amgen Canada Inc., in the first ever patent infringement/patent validity trial and appeal under the new Patented Medicines (Notice of Compliance) Regulations.
Auro Pharma, in navigating the Patent Act and Patented Medicines (Notice of Compliance) Regulations to get drugs to market.
Canadian Natural Resources Ltd (CNRL), in a patent infringement/patent validity lawsuit by Maoz Betser-Zilevitch.
Kensington Capital Partners and Kensington Private Equity Fund in the $35-million acquisition and related financing through its portfolio company, Clearpoint Health Network Inc., of the surgical and medical centres business of Centric Health Corporation, a TSX listed company, and subsequent reorganization of Clearpoint . [Kensington Capital Advisors Inc. is a leading independent investor in alternative assets with over $1.5 billion invested in private equity and alternative assets.]
Marc Anthony Cosmetics, Inc., in a trademark and trade dress infringement, passing off and unfair competition Federal Court action launched by Moroccanoil.
Locke v Osler, Hoskin & Harcourt LLP, 2011 FC 1390
Auro Pharma, in patent litigation proceedings commenced by GlaxoSmithKline. Court File No. T-1766-13.
Teva Canada, respondent drug manufacturer, in applications by a competitor to prohibit the Minister of Health from issuing a Notice of Compliance to Teva for the drug moxifloxacin. Court File Nos. T-1414-13 and T-1415-13.
A biologics manufacturer in advice regarding biosimilar regulatory and patent barriers, and preparation of Notices of Allegation.
A pharmaceutical company in applications by a competitor to prohibit the Minister of Health from issuing a Notice of Compliance.

Recent Recognition

Managing IP: IP Stars
Recognized as a Rising Star – Canada

Insights, News & Events

Announcements

Bennett Jones Welcomes 10 New Partners

March 08, 2023
       

Blog

Stay Here or There? Recent Direction from the Québec Court of Appeal on Stays in Proposed Parallel Class Proceedings

October 29, 2020
       

Related Services

Intellectual Property Law
Intellectual Property Litigation
Biotech, Pharma & Lifesciences
Technology, Media & Entertainment
Data Governance Protection & Cybersecurity
Privacy & Data Protection
Class Action Litigation
Bennett Jones Centennial Footer
Bennett Jones Centennial Footer
About
  • Leadership
  • Diversity
  • Community
  • Innovation
  • Security
  • History
Offices
  • Calgary
  • Edmonton
  • Montréal
  • Ottawa
  • Toronto
  • Vancouver
  • New York
Connect
  • Insights
  • News
  • Events
  • Careers
  • Students
  • Alumni
Subscribe

Stay informed on the latest business and legal insights and events.

LinkedIn LinkedIn Twitter Twitter Vimeo Vimeo
© Bennett Jones LLP 2023. All rights reserved.
  • Privacy Policy
  • Disclaimer
  • Terms of Use
Logo Bennett Jones